nav-left cat-right
cat-right

Cosmic Rays Alter Chemistry of Lunar Ice, May Crea...

Space scientists from the University of New Hampshire and multi-institutional colleagues report they have quantified levels of radiation on the moon’s surface from galactic cosmic ray (GCR) bombardment that over time causes chemical changes in water ice and can create complex carbon chains similar to those that help form the foundations of biological structures. In addition, the radiation process causes the lunar soil,...

FDA approves RTP firm’s blood screening test

By FRANK VINLUAN, MedCity News Research Triangle Park, N.C. — The U.S. Food and Drug Administration has approved a new test for blood donations, just the second test available to screen for two viruses linked to leukemia and neurologic disorders. The blood test, developed by medical device company Avioq, detects antibodies to human T-lymphotropic virus type 1 (HTLV 1) and human T-lymphotropic virus type 2 (HTLV 2). In...

Ortho-Clinical Diagnostics Announces Availability ...

The FINANCIAL — Ortho Clinical Diagnostics announced the availability of the Avioq HTLV-I/II Microelisa System assay, a new test developed in partnership with Avioq, Inc. to screen blood and organ donations for antibodies to human T-lymphotropic virus type I and II. Screening for antibodies to HTLV-I/II is required by the United States Food and Drug Administration for the nearly 16 million blood donations collected in...

HTLV blood screening test from RTP diagnostics fir...

The U.S. Food and Drug Administration has approved a new test for blood donations, just the second test available to screen for two viruses linked to leukemia and neurologic disorders. The blood test, developed by medical device company Avioq, detects antibodies to human T-lymphotropic virus type 1 (HTLV 1) and human T-lymphotropic virus type 2 (HTLV 2). In addition to screening blood donors for the presence of the viruses,...

Dow AgroSciences, Dualsystems Biotech Announce Pro...

INDIANAPOLIS & ZURICH, Mar 21, 2012 (BUSINESS WIRE) — Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company DOW -1.63% , and Dualsystems Biotech announced today, a drug profiling agreement. Under the agreement, Dualsystems Biotech will use its drug profiling platform to identify molecular targets for an undisclosed small molecule lead candidate in Dow AgroSciences’ agrochemical discovery...

Stool DNA Test for CRC Is Improving New Data Show ...

by Caroline Helwick San Francisco—New-generation stool DNA testing for colorectal cancer (CRC) screening offers “extraordinarily” high detection rates for cancers and precancers that are likely to progress, said David Ahlquist, MD, professor of medicine, Department of Gastroenterology and Hepatology at the Mayo Clinic, Rochester, Minn., who helped develop this approach and presented recent findings at the 2012 American...
Page 30 of 92« First...1020...2829303132...405060...Last »